The Filings Report

Becton, Dickinson and Co.

BDXNYSECIK 10795Healthcare / Medical Devicesfiscal year ends September73 quarters since 2008

Revenue, Q3 FY2026
$5.0B
no year-earlier figure
Net income
$377M
−34.3% on Q3 FY2025
Free cash flow
$633M
−31.6% on Q3 FY2025
Diluted EPS
$1.37
−31.5% on Q3 FY2025
Revenue, TTM
—
trailing four quarters
Net margin, TTM
—
net income $941M
Free cash flow, TTM
$3.2B
$4.0B less $753M capex
Cash and equivalents
$708M
long-term debt $13.5B, Jun 30, 2026
Shares, 12-month change
−5.0%
272M shares, Jun 30, 2026
Buybacks, TTM
$2.5B
4.6% of market value
Dividends, TTM
$1.2B
2.2% of market value
Market value
$53.9B
at the close, buybacks

Latest quarter Q3 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended June 30, 2026, Becton, Dickinson and Co. reported revenue of $5.0B, and net income of $377M (−34.3%). Operating margin was 13.3%. Free cash flow, operating cash flow less capital expenditures, was $633M ($776M less $143M). Diluted earnings per share were $1.37.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of August 6, 2026.

Revenue and net incomeRevenueNet income
−$2B$0$2B$4B$6BQ4'22, Revenue: $4.8BQ4'22, Net income: $288MQ4'22Q1'23, Revenue: $4.6BQ1'23, Net income: $509MQ1'23Q2'23, Revenue: $4.8BQ2'23, Net income: $460MQ2'23Q3'23, Revenue: $4.9BQ3'23, Net income: $407MQ3'23Q4'23, Revenue: $5.1BQ4'23, Net income: $108MQ4'23Q1'24, Revenue: $4.7BQ1'24, Net income: $281MQ1'24Q2'24, Revenue: $5.0BQ2'24, Net income: $537MQ2'24Q3'24, Revenue: $5.0BQ3'24, Net income: $487MQ3'24Q4'24, Revenue: $5.4BQ4'24, Net income: $400MQ4'24Q1'25, Net income: $303MQ1'25Q2'25, Net income: $308MQ2'25Q3'25, Net income: $574MQ3'25Q4'25, Net income: $493MQ4'25Q1'26, Revenue: $5.3BQ1'26, Net income: $382MQ1'26Q2'26, Revenue: $4.7BQ2'26, Net income: −$311MQ2'26Q3'26, Revenue: $5.0BQ3'26, Net income: $377MQ3'26−$2B$0$2B$4B$6BQ4'22, Revenue: $4.8BQ4'22, Net income: $288MQ1'23, Revenue: $4.6BQ1'23, Net income: $509MQ1'23Q2'23, Revenue: $4.8BQ2'23, Net income: $460MQ3'23, Revenue: $4.9BQ3'23, Net income: $407MQ3'23Q4'23, Revenue: $5.1BQ4'23, Net income: $108MQ1'24, Revenue: $4.7BQ1'24, Net income: $281MQ1'24Q2'24, Revenue: $5.0BQ2'24, Net income: $537MQ3'24, Revenue: $5.0BQ3'24, Net income: $487MQ3'24Q4'24, Revenue: $5.4BQ4'24, Net income: $400MQ1'25, Net income: $303MQ1'25Q2'25, Net income: $308MQ3'25, Net income: $574MQ3'25Q4'25, Net income: $493MQ1'26, Revenue: $5.3BQ1'26, Net income: $382MQ1'26Q2'26, Revenue: $4.7BQ2'26, Net income: −$311MQ3'26, Revenue: $5.0BQ3'26, Net income: $377MQ3'26

Net income losses drawn in red.

Free cash flow
−$500M$0$500M$1.0B$1.5BQ4'22, Free cash flow: $658MQ4'22Q1'23, Free cash flow: $191MQ1'23Q2'23, Free cash flow: $4MQ2'23Q3'23, Free cash flow: $890MQ3'23Q4'23, Free cash flow: $1.0BQ4'23Q1'24, Free cash flow: $739MQ1'24Q2'24, Free cash flow: $380MQ2'24Q3'24, Free cash flow: $1.1BQ3'24Q4'24, Free cash flow: $882MQ4'24Q1'25, Free cash flow: $588MQ1'25Q2'25, Free cash flow: −$318MQ2'25Q3'25, Free cash flow: $925MQ3'25Q4'25, Free cash flow: $1.5BQ4'25Q1'26, Free cash flow: $549MQ1'26Q2'26, Free cash flow: $546MQ2'26Q3'26, Free cash flow: $633MQ3'26−$500M$0$500M$1.0B$1.5BQ4'22, Free cash flow: $658MQ1'23, Free cash flow: $191MQ1'23Q2'23, Free cash flow: $4MQ3'23, Free cash flow: $890MQ3'23Q4'23, Free cash flow: $1.0BQ1'24, Free cash flow: $739MQ1'24Q2'24, Free cash flow: $380MQ3'24, Free cash flow: $1.1BQ3'24Q4'24, Free cash flow: $882MQ1'25, Free cash flow: $588MQ1'25Q2'25, Free cash flow: −$318MQ3'25, Free cash flow: $925MQ3'25Q4'25, Free cash flow: $1.5BQ1'26, Free cash flow: $549MQ1'26Q2'26, Free cash flow: $546MQ3'26, Free cash flow: $633MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $1.0BQ4'22, Long-term debt: $13.9BQ4'22Q1'23, Cash and equivalents: $612MQ1'23, Long-term debt: $14.3BQ1'23Q2'23, Cash and equivalents: $2.0BQ2'23, Long-term debt: $16.0BQ2'23Q3'23, Cash and equivalents: $923MQ3'23, Long-term debt: $14.9BQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $14.7BQ4'23Q1'24, Cash and equivalents: $1.2BQ1'24, Long-term debt: $14.1BQ1'24Q2'24, Cash and equivalents: $2.3BQ2'24, Long-term debt: $16.0BQ2'24Q3'24, Cash and equivalents: $4.5BQ3'24, Long-term debt: $18.1BQ3'24Q4'24, Cash and equivalents: $1.7BQ4'24, Long-term debt: $17.9BQ4'24Q1'25, Cash and equivalents: $711MQ1'25, Long-term debt: $17.4BQ1'25Q2'25, Cash and equivalents: $667MQ2'25, Long-term debt: $17.7BQ2'25Q3'25, Cash and equivalents: $735MQ3'25, Long-term debt: $17.5BQ3'25Q4'25, Cash and equivalents: $567MQ4'25, Long-term debt: $17.6BQ4'25Q1'26, Cash and equivalents: $740MQ1'26, Long-term debt: $16.9BQ1'26Q2'26, Cash and equivalents: $813MQ2'26, Long-term debt: $14.7BQ2'26Q3'26, Cash and equivalents: $708MQ3'26, Long-term debt: $13.5BQ3'26$0$5B$10B$15B$20BQ4'22, Cash and equivalents: $1.0BQ4'22, Long-term debt: $13.9BQ1'23, Cash and equivalents: $612MQ1'23, Long-term debt: $14.3BQ1'23Q2'23, Cash and equivalents: $2.0BQ2'23, Long-term debt: $16.0BQ3'23, Cash and equivalents: $923MQ3'23, Long-term debt: $14.9BQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $14.7BQ1'24, Cash and equivalents: $1.2BQ1'24, Long-term debt: $14.1BQ1'24Q2'24, Cash and equivalents: $2.3BQ2'24, Long-term debt: $16.0BQ3'24, Cash and equivalents: $4.5BQ3'24, Long-term debt: $18.1BQ3'24Q4'24, Cash and equivalents: $1.7BQ4'24, Long-term debt: $17.9BQ1'25, Cash and equivalents: $711MQ1'25, Long-term debt: $17.4BQ1'25Q2'25, Cash and equivalents: $667MQ2'25, Long-term debt: $17.7BQ3'25, Cash and equivalents: $735MQ3'25, Long-term debt: $17.5BQ3'25Q4'25, Cash and equivalents: $567MQ4'25, Long-term debt: $17.6BQ1'26, Cash and equivalents: $740MQ1'26, Long-term debt: $16.9BQ1'26Q2'26, Cash and equivalents: $813MQ2'26, Long-term debt: $14.7BQ3'26, Cash and equivalents: $708MQ3'26, Long-term debt: $13.5BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed August 6, 2026.

Becton, Dickinson and Co. income statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 6, 2026Q2 FY2026ended Mar 31, 2026filed May 7, 2026Q1 FY2026ended Dec 31, 2025filed Feb 9, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 7, 2025Q2 FY2025ended Mar 31, 2025filed May 1, 2025Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025Q4 FY2024ended Sep 30, 2024filed Nov 27, 2024YoYQ3 FY2026vs Q3 FY2025
Revenue4,9834,7145,252withheldwithheldwithheldwithheld5,437—
Cost of revenue2,6682,5602,841withheldwithheldwithheldwithheld2,950—
Gross profit—————————
Research and development258249306559230232343302+12.2%
Selling, general and administrative1,2611,2131,393withheldwithheldwithheldwithheld1,256—
Operating income66393552withheldwithheldwithheldwithheld622—
Other income (expense)1986(10)(51)(22)(36)(16)(9)+186.4%
Pretax income55439393withheldwithheldwithheldwithheld514—
Income tax102761152118433114−13.6%
Net income377(311)382493574308303400−34.3%
Diluted EPS ($)1.37(1.11)1.34—2.001.071.04—−31.5%
Diluted shares (millions)275281286—287288290——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed August 6, 2026.

Becton, Dickinson and Co. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 6, 2026Q2 FY2026ended Mar 31, 2026filed May 7, 2026Q1 FY2026ended Dec 31, 2025filed Feb 9, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 7, 2025Q2 FY2025ended Mar 31, 2025filed May 1, 2025Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025Q4 FY2024ended Sep 30, 2024filed Nov 27, 2024YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents7088137405677356677111,717−3.7%
Short-term investments—————————
Total current assets8,1398,0129,1899,2558,9978,6668,65910,468−9.5%
Total assets50,73150,83254,84155,32554,90254,46754,66557,286−7.6%
Total current liabilities9,4048,5078,7618,3138,1607,6917,6648,956+15.2%
Long-term debt13,51114,70616,91617,62017,53117,66617,44017,940−22.9%
Total liabilities—————————
Stockholders’ equity24,41624,13325,28225,39025,47225,24125,20525,890−4.1%
Shares outstanding (millions)272276285285287287287289—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed August 6, 2026.

Becton, Dickinson and Co. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 6, 2026Q2 FY2026ended Mar 31, 2026filed May 7, 2026Q1 FY2026ended Dec 31, 2025filed Feb 9, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 7, 2025Q2 FY2025ended Mar 31, 2025filed May 1, 2025Q1 FY2025ended Dec 31, 2024filed Feb 6, 2025Q4 FY2024ended Sep 30, 2024filed Nov 27, 2024YoYQ3 FY2026vs Q3 FY2025
Operating cash flow7766716571,8521,089(204)6931,178−28.7%
Capital expenditures143125108377164114105296−12.8%
Free cash flow (CFO − capex)6335465491,475925(318)588882−31.6%
Depreciation and amortization564563614withheldwithheldwithheldwithheld586—
Share repurchases02,000250250007500—
Dividends paid286290299297299298302275−4.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed November 25, 2025.

Income statement

Becton, Dickinson and Co. income statement, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 27, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 24, 2021FY2020ended Sep 30, 2020filed Nov 25, 2020FY2019ended Sep 30, 2019filed Nov 27, 2019FY2018ended Sep 30, 2018filed Nov 21, 2018FY2017ended Sep 30, 2017filed Nov 22, 2017FY2016ended Sep 30, 2016filed Nov 23, 2016FY2015ended Sep 30, 2015filed Nov 25, 2015FY2014ended Sep 30, 2014filed Nov 26, 2014FY2013ended Sep 30, 2013filed Nov 27, 2013FY2012ended Sep 30, 2012filed Nov 21, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 30, 2010filed Nov 24, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 10, 2009FY2007ended Sep 30, 2007filed Aug 10, 2009
Revenue21,84020,17819,37218,87019,13116,07417,29015,98312,09312,48310,2828,4468,0547,7087,5847,1246,9876,8986,283
Cost of revenue11,91511,05311,20210,39310,5009,2769,0028,7146,1286,4925,5874,1453,8833,7553,6253,4283,3123,3573,033
Gross profit—————7,5778,2887,2695,9425,9914,6954,301———————
Research and development1,2651,1901,2371,2561,2791,0391,0621,004770828632550494472470423405——
Selling, general and administrative5,2784,8574,7194,7094,7194,1854,3324,0162,9093,0052,5632,1452,4221,9231,8241,6911,6811,6701,584
Operating income2,5792,3972,1112,2822,2509121,7601,5091,5221,4301,0741,6061,2541,5581,6661,5821,5901,4881,185
Other income (expense)(123)(28)(46)(117)(99)2343305(101)112159(1)(7)0(4)(1)1
Pretax income1,8812,0051,6621,7831,6924141,1761,1739761,0747391,5221,1651,4721,6181,5671,5791,4901,185
Income tax2033001321488862(57)862(124)9744337236363417452411412344
Net income1,6781,7051,4841,7792,0928741,2333111,1009766951,1851,2931,170——1,2321,127890
Diluted EPS ($)5.825.864.945.886.852.713.940.604.604.493.355.996.495.595.625.494.994.463.49
Diluted shares (millions)289291288287292282275265224218208198199209226240247253—

Balance sheet

Becton, Dickinson and Co. balance sheet, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 27, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 24, 2021FY2020ended Sep 30, 2020filed Nov 25, 2020FY2019ended Sep 30, 2019filed Nov 27, 2019FY2018ended Sep 30, 2018filed Nov 21, 2018FY2017ended Sep 30, 2017filed Nov 22, 2017FY2016ended Sep 30, 2016filed Nov 23, 2016FY2015ended Sep 30, 2015filed Nov 25, 2015FY2014ended Sep 30, 2014filed Nov 26, 2014FY2013ended Sep 30, 2013filed Nov 27, 2013FY2012ended Sep 30, 2012filed Nov 21, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 30, 2010filed Nov 24, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 10, 2009FY2007ended Sep 30, 2007filed Aug 10, 2009
Cash and equivalents5671,7171,4161,0062,2832,8255361,14014,1791,5411,4241,8611,8901,6711,1751,2161,394830511
Short-term investments———————————————————
Total current assets9,25510,4688,6768,1418,8388,9696,6647,41118,6336,3675,6596,1315,8735,3224,6684,5054,6473,615—
Total assets55,32557,28652,78052,93453,86654,01251,76553,90437,73425,58626,47812,38412,14911,36110,4309,6519,3057,913—
Total current liabilities8,3138,9566,6417,8116,6265,8365,6557,2163,3424,4004,3812,2352,1301,9781,8231,6721,7771,417—
Long-term debt17,62017,94014,73813,88617,11017,22418,08118,89418,66710,55011,3703,7683,7633,7612,4851,4951,488——
Total liabilities———————————————————
Stockholders’ equity25,39025,89025,79625,28223,67723,76521,08120,99412,9487,6337,1645,0535,0434,1364,8285,4355,1434,936—
Shares outstanding (millions)285289290283284290270268228212211192194197215230237——

Cash flow statement

Becton, Dickinson and Co. cash flow statement, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 27, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 24, 2021FY2020ended Sep 30, 2020filed Nov 25, 2020FY2019ended Sep 30, 2019filed Nov 27, 2019FY2018ended Sep 30, 2018filed Nov 21, 2018FY2017ended Sep 30, 2017filed Nov 22, 2017FY2016ended Sep 30, 2016filed Nov 23, 2016FY2015ended Sep 30, 2015filed Nov 25, 2015FY2014ended Sep 30, 2014filed Nov 26, 2014FY2013ended Sep 30, 2013filed Nov 27, 2013FY2012ended Sep 30, 2012filed Nov 21, 2012FY2011ended Sep 30, 2011filed Nov 23, 2011FY2010ended Sep 30, 2010filed Nov 24, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 10, 2009FY2007ended Sep 30, 2007filed Aug 10, 2009
Operating cash flow3,4303,8442,9902,4714,1262,9373,3302,8652,5502,5591,7301,7461,7171,6931,6381,5871,6581,6181,230
Capital expenditures7607258749731,194769957895727693596592522487509531585596556
Free cash flow (CFO − capex)2,6703,1192,1161,4982,9322,1682,3731,9701,8231,8661,1341,1541,1951,2061,1291,0561,0731,022674
Depreciation and amortization2,4622,2862,2882,2292,2302,1152,2531,9781,0881,114891562546511494491465472441
Share repurchases1,00050005001,750000220004004501,5001,500750550450450
Dividends paid1,1961,1001,1141,0821,0481,026984927677562485421386368361346317279240

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$1M
5 sales by 3 insiders; officers and directors $1M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$3M
22 sales by 5 insiders; officers and directors $3M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-176$198.13$15K19,568Oct 27, 2026
Sep 28, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-176$183.70$14K19,644Sep 29, 2026
Sep 2, 2026Roque VitorEVP & Chief Financial Officertax withholding190$0.00—8,041Sep 3, 2026
Aug 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-1165$188.49$31K19,720Aug 27, 2026
Aug 20, 2026Feld MichaelEVP, Chief Revenue Officertax withholding1,049$0.00—19,885Aug 24, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directoroption exercise43,278$167.25$7M153,441Aug 14, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directordisposition to issuer39,126$185.00$7M114,315Aug 14, 2026
Aug 13, 2026Polen Thomas E JrChairman, CEO and President, Directoropen-market sale10b5-14,152$185.00$768K110,163Aug 14, 2026
Aug 11, 2026Goette RolandEVP and President, EMEAopen-market sale2,438$180.84$441K14,856Aug 12, 2026
Jul 27, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$157.13$12K20,934Jul 28, 2026
Jul 2, 2026Muhsin BilalEVP & President Connected Caretax withholding1,935$0.00—41,359Jul 6, 2026
Jul 1, 2026Muhsin BilalEVP & President Connected Careaward14,342$0.00—43,294Jul 6, 2026
Jun 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$152.80$11K21,009Jun 26, 2026
Jun 24, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-11,100$145.66$160K13,172Jun 25, 2026
Jun 10, 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmopen-market sale10b5-11,100$151.48$167K14,272Jun 11, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directoroption exercise20,209$126.16$3M125,680Jun 3, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directordisposition to issuer17,445$146.15$3M108,235Jun 3, 2026
Jun 1, 2026Polen Thomas E JrChairman, CEO and President, Directoropen-market sale10b5-12,764$146.35$405K110,163Jun 3, 2026
Jun 1, 2026Menziuso PeterEVP and President, BDIaward14,258$0.00—14,258Jun 2, 2026
May 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$147.35$11K21,084May 27, 2026
May 7, 2026Roque VitorEVP & Chief Financial Officeraward1,721$0.00—8,231May 8, 2026
Apr 27, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-174$151.94$11K21,159Apr 28, 2026
Apr 6, 2026Neal Shana CarolEVP and Chief People Officertax withholding1,146$0.00—23,966Apr 6, 2026
Mar 26, 2026Feld MichaelEVP, Chief Revenue Officeropen-market sale10b5-175$156.83$12K21,233Mar 27, 2026
Mar 16, 2026Minnix LaneshaEVP and General Counselaward7,492$0.00—7,492Mar 17, 2026

Full insider history for Becton, Dickinson and Co., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 9; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
BECTON, DICKINSON AND COMPANY, CIK 10795 on EDGAR
Extract generated
August 27, 2026
Withheld
15 line-years whose four quarters do not sum to the filed year: cost of revenue FY2011, operating income FY2011, pretax income FY2011, revenue FY2011, revenue FY2020, cost of revenue FY2021, operating income FY2021, pretax income FY2021, revenue FY2021, depreciation amortization FY2025, cost of revenue FY2025, operating income FY2025, opex sga FY2025, pretax income FY2025, revenue FY2025
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: pretax income FY2020
XBRL concepts behind each line

Income statement

Revenue: Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities, NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/BDX.json